ABUS Operating Cash Flow (Statement)
Arbutus Biopharma Corp · Operating Cash Flow (Statement)
ABUS Operating Cash Flow (Statement)
Latest reported-$24.62Mperiod ending
ABUS Cash from Operations (-$7.71M → -$24.62M)
Annual operating cash flow (statement)
High-resolution chart · PNG
ABUS operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -39,637,000 | |
| -64,850,000 | |
| -85,936,000 | |
| -35,356,000 | |
| -67,532,000 | |
| -51,441,000 | |
| -71,006,000 | |
| -67,900,000 | |
| -48,600,000 | |
| -57,885,000 | |
| -54,785,000 | |
| -12,421,000 | |
| -6,738,559 | |
| 33,270,564 | |
| -7,520,670 | |
| -11,246,709 | |
| -5,239,004 | |
| -8,484,329 | |
| -2,719,689 | |
| -2,623,161 | |
| -14,573,489 | |
| -9,982,651 | |
| -26,964,108 | |
| -18,156,698 | |
| -10,003,985 | |
| -8,353,539 | |
| -6,836,512 | |
| -7,708,895 |